Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease

Clinical Efficacy of Trimetazidine and Holistic Management in the Treatment of Coronary Heart Disease

Background: To investigate the clinical efficacy of trimetazidine and holistic management in the treatment of coronary heart disease. Methods: A total of 128 cases of patients with coronary heart disease were admitted in The Second Affiliated Hospital of Dalian Medical University from October 20...

Full description

Bibliographic Details
Main Authors:	Li QU, Hua JIANG
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2018-06-01
Series:	Iranian Journal of Public Health
Subjects:	Coronary heart disease Trimetazidine Clinical efficacy Nursing experience
Online Access:	https://ijph.tums.ac.ir/index.php/ijph/article/view/13757

Similar Items

Efficacy of trimetazidine combining with metoprolol on plasma BNP in coronary heart disease patients with heart failure
by: Ping Li, et al.
Published: (2016-01-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

Effect of atorvastatin combined with trimetazidine on heart function, oxidative stress and inflammatory factors in patients with coronary heart disease
by: De-Mao Yi, et al.
Published: (2017-05-01)

Trimetazidine in Heart Failure
by: Hongyang Shu, et al.
Published: (2021-01-01)

ANTIISCHEMIC METABOLIC MODULATOR TRIMETAZIDINE IN TREATMENT OF CORONARY HEART DISEASE
by: V. P. Lupanov
Published: (2017-02-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

Therapeutic possibilities of myocardial cytoprotector trimetazidine MR incoronary heart disease
by: D. I Trukhan
Published: (2014-12-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

The impact of preoperative trimetazidine use on oxidative parameters in patients undergoing coronary bypass surgery
by: Aydemir Koçarslan, et al.
Published: (2013-12-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

MYOCARDIAL CYTOPROTECTOR TRIMETAZIDINE MB-PREPARAT, INCREASES THE EFFECTIVENESS OF TREATMENT OF CHRONIC HEART FAILURE AND CORONARY HEART DISEASE
by: D. I. Trukhan, et al.
Published: (2017-12-01)

Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease
by: Т A Fedorova, et al.
Published: (2004-03-01)

Effect of atorvastatin combined with trimetazidine on oxidative stress, hemorheology, and NT-proBNP, hs-CRP in patients with coronary heart disease
by: Li-Yan Wang, et al.
Published: (2017-09-01)

TRIMETAZIDINE MB ROLE IN THE OPTIMISATION OF THE ACUTE CORONARY SYNDROME TREATMENT: EFFECTS ON ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION
by: S. I. Davydov, et al.
Published: (2013-12-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

MYOCARDIAL DAMAGE BIOMARKERS DYNAMICS AFTER EXTRACARDIAC SURGERY IN CORONARY HEART DISEASE PATIENTS TAKING TRIMETAZIDINE MR
by: O. A. Bolshedvorskaya, et al.
Published: (2017-05-01)

The Clinical Short-term Outcome of Atorvastatin and Trimetazidine Combination Treatment in Patients with Non-ST Segment Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Jiang-you Wang, et al.
Published: (2016-01-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

Clinical effectiveness of trimetazidine as a leading cardiovascular drug with metabolic action
by: A. Yu. Gasparyan, et al.
Published: (2008-08-01)

Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK
by: Hongyang Shu, et al.
Published: (2021-09-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

Effect of Trimetazidine Dihydrochloride Tablets adjuvant therapy on inflammatory reaction, oxidative stress, vascular endothelial function and myocardial function in patients with coronary heart disease complicated with heart failure
by: Cai-Wen Wei, et al.
Published: (2017-11-01)

Effect of trimetazidine and glucose- insulin-potassium use on myocard during beating heart coronary artery bypass surgery
by: Abdulkadir Ercan, et al.
Published: (2011-12-01)

Reactive oxygen species production by blood leukocytes and its correction by trimetazidine MB in patients with acute coronary syndrome
by: M. G. Glezer, et al.
Published: (2009-08-01)

Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice
by: Yu V Luneva, et al.
Published: (2019-08-01)

Effects of trimetazidine and perindopril on myocardialfunction and metabolism in postmyocardial infarction patients with cardiac failure
by: A V Shabrov, et al.
Published: (2003-09-01)

Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine
by: Suman Jatain, et al.
Published: (2016-11-01)

Personalized trimetazidine prescription as a cytoprotective agent in patients with coronary artery disease
by: O. V. Romashchenko
Published: (2021-07-01)

Trimetazidine-Induced Parkinsonism: A Systematic Review
by: Anna Marielle B. Dy, et al.
Published: (2020-02-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

ACPTI study: Being positive in a negative situation is not naivety – Trimetazidine still has role in symptomatic CAD patients
by: Jamshed Dalal, et al.
Published: (2021-01-01)

Effect of Qishen Yiqi dripping pills combined with trimetazidine on the treatment of chronic heart failure: A meta-analysis
by: Feng Xie, et al.
Published: (2021-05-01)

Effect of atorvastatin and trimetazidine combination treatment in patients with NSTE-ACS undergoing PCI
by: Jiang-You Wang, et al.
Published: (2018-01-01)